Novo Nordisks oral semaglutide 25 mg (Wegovy in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant…
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET Â | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…